glucose, (beta-d)-isomer has been researched along with Diabetes Mellitus in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (7.76) | 18.7374 |
| 1990's | 1 (0.86) | 18.2507 |
| 2000's | 7 (6.03) | 29.6817 |
| 2010's | 50 (43.10) | 24.3611 |
| 2020's | 49 (42.24) | 2.80 |
| Authors | Studies |
|---|---|
| Basyreva, LY; Gusev, SA; Lipatova, VA; Mikhalchik, EV; Panasenko, OM; Sergienko, VI | 1 |
| Ding, Y; Hasturk, H; Kantarci, A; Malabanan, A; Trackman, PC; Van Dyke, TE | 1 |
| Cech, P; Frei, J; Markert, M | 1 |
| Eilen, SD; Shah, SV; Wallin, JD | 1 |
| Larkins, RG; Qvist, R | 1 |
| Csató, M; Dobozy, A; Simon, N | 1 |
| Blodgett, JL; Bloodworth, RC; McManus, LM; Pinckard, RN; Prihoda, TJ | 1 |
| Siekierka, H; Szczepanik, A; Wierusz-Wysocka, B; Wykretowicz, A; Wysocki, H | 1 |
| Stewart, J; Weir, DM | 1 |
| Davies, RR; Denning, TJ | 1 |
| Alpers, CE; Holland, AL; Hudkins, KL; Li, X; Swaminathan, S | 1 |
| Fan, X; Guo, F; Huang, F; Liu, Y; Qin, G; Song, Y; Zhao, L | 1 |
| Egan, EM; Remedi, MS; Shyr, ZA; Ustione, A; Yan, Z | 1 |
| Huang, X; Liu, X; Qiao, Y; Xi, W; Zeng, K | 1 |
| Gao, Y; Li, X; Xu, L; Yang, X; Zhu, Y | 1 |
| Cao, F; Chen, G; Guo, X; Huang, X; Qiao, Y; Tang, C; Wang, D; Yan, G; Yao, Y; Zhang, W; Zhang, Y | 1 |
| Damas-Fuentes, M; Fernández-Valero, A; Martínez-Montoro, JI; Pinzón-Martín, JL; Tinahones, FJ | 1 |
| Anzai, K; Takahashi, H | 1 |
| de Knegt, RJ; van Kleef, LA | 1 |
| Gong, W; Gu, W; Jia, Z; Mei, J; Piao, Z; Qin, L; You, D; Yu, H | 1 |
| Abegaz, TM; Ali, AA; Diaby, V; Sherbeny, F | 1 |
| Albanese, C; Choos, END; Ecelbarger, CM; Jones, BA; Knoer, G; Kurtz, R; Lee, Y; Levi, M; Libby, A; Lo Cascio, JN; McCormack, M; Myakala, K; Nguyen, G; Ranjit, S; Rodriguez, O; Rosenberg, AZ; Shepard, BD; Wang, X | 1 |
| Chen, S; Luo, J; Piao, C; Wang, L; Zhao, X | 1 |
| Abu Shamsi, MY; Ismail, I; Kamaruddin, NA; Sukor, N; Wan Azman, SS | 1 |
| Chepulis, L; Paul, R; Yu, A | 1 |
| Dai, X; Hao, H; Li, Y; Ou, T; Wang, D; Wang, R; Wang, W; Yong, H | 1 |
| Dural, İE; Ersoy, İ; Sarı, A | 1 |
| Huang, B; Wen, W; Ye, S | 1 |
| Gao, L; Huang, YB; Jiang, L; Liu, XQ; Wang, AL; Wang, X; Wu, YG; Xia, LL; Zeng, HX; Zhu, QJ | 1 |
| Choi, D; Hong, GR; Jeon, OH; Kim, C; Kim, D; Kim, JS; Lee, CJ; Lee, HJ; Lee, JJ; Lee, OH; Lee, SG; Lee, SJ; Lee, YH; Lee, YJ; Moon, RK; Oh, J; Park, S | 1 |
| Dai, Y; Fang, LJ; Hu, B; Lu, YP; Tang, C; Tang, DE; Wu, HW; Yin, L; Zhang, YQ; Zhang, ZY; Zheng, ZH; Zhu, T | 1 |
| Fudim, M; Van Spall, HGC | 1 |
| Li, R; Liu, Y; Tan, CP; Xu, YJ; Yang, W; Ye, Z | 1 |
| Agafonova, A; Anfuso, CD; Cosentino, A; Giurdanella, G; Longo, A; Lupo, G; Rusciano, D | 1 |
| Attallah, N; Yassine, L | 1 |
| Dun, Y; Jiang, L; Li, H; Liu, S; Liu, Y; Xie, M; You, B; Zhang, W | 1 |
| Abraham, NG; Arad, M; Aravot, D; Arow, M; Freimark, D; Hochhauser, E; Kornowski, R; Nudelman, V; Shainberg, A; Waldman, M; Yadin, D | 1 |
| Shati, AA | 1 |
| Ebihara, K; Ishibashi, S; Nagashima, S; Okada, K; Saito, N; Takahashi, M; Wakabayashi, T | 1 |
| Arnott, C; Neal, B | 1 |
| Burren, CP; Candler, T; McGregor, D; Moudiotis, C; Narayan, K | 1 |
| Gollapalli, BP; Gorantala, J; Magani, SKJ; Mupparthi, SD; Shukla, D; Tantravahi, S; Tiwari, AK; Yarla, NS | 1 |
| Cho, JH; Kim, H; Kim, HS; Lee, H; Lee, SH; Yim, HW; Yoon, KH | 1 |
| Bakris, GL; Sternlicht, HK | 1 |
| Costantino, S; Hamdani, N; Paneni, F | 1 |
| Lim, GB | 2 |
| Demarest, K; Du, F; Gaul, MD; Kuo, GH; Liang, Y; Xu, G; Xu, JZ | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Tuttle, KR | 1 |
| Heerspink, HJL; Muskiet, MHA; van Raalte, DH | 1 |
| Chuntakaruk, H; Kongtawelert, P; Pothacharoen, P | 1 |
| Li, X; Liu, K; Long, J; Xie, L; Xie, Q; Zhang, X; Zheng, Y | 1 |
| Kang, L; Liu, Y; Wu, M; Xu, B; Xu, J | 1 |
| Cabrera-Nájera, LE; Chirino-Galindo, G; Estrella-Parra, EA; García-Bores, AM; López-Quintero, IV; Palomar-Morales, M; Ramírez-Domínguez, LB | 1 |
| Au Yeung, J; Khong, TK | 1 |
| Dai, X; Duan, JA; Qian, D; Shang, EX; Su, S; Wang, Q; Wei, D; Xiang, X; Xu, Z; Zheng, T | 1 |
| Akihisa, T; Cai, J; Feng, F; Kikuchi, T; Li, W; Li, Y; Liu, W; Xu, J; Zhang, J; Zhu, W | 1 |
| Imai, J; Katagiri, H; Kawana, Y; Sawada, S; Yamada, T | 1 |
| Abbate, A; Baker, WL; Brown, R; Bucheit, JD; Buckley, LF; Carbone, S; Dixon, DL; Kelly, MS; Parod, ED | 1 |
| Greenfield, JR; MacDonald, PS; Muir, CA | 1 |
| Chan, MJ; Hsu, CW; Huang, WH; Weng, CH; Yen, TH | 1 |
| Tian, L; Wu, S | 1 |
| Abassi, Z; Hollander, K; Landa, N; Leor, J; Naftali-Shani, N; Rath, L; Rosenthal, T; Younis, F | 1 |
| Miyamoto, L; Tsuchiya, K | 1 |
| de Albuquerque Rocha, N; McCullough, PA; McGuire, DK; Neeland, IJ; Toto, RD | 1 |
| Assanga, SBI; McCarty, MF | 1 |
| Abdurrachim, D; Manders, E; Mayoux, E; Nicolay, K; Prompers, JJ | 1 |
| Claggett, B; Fitchett, D; George, JT; Hantel, S; Inzucchi, SE; Lachin, JM; Woerle, HJ; Zinman, B | 1 |
| Kakizaki, S; Kikuchi, O; Kitamura, T; Kobayashi, M; Kohno, D; Matsui, S; Sasaki, T; Suga, T; Takeuchi, K; Wada, E; Yamada, M; Yokota-Hashimoto, H | 1 |
| Adam, J; Ashcroft, FM; Asterholm, IW; Benrick, A; Briant, LJB; Chibalina, MV; Gribble, FM; Hamilton, A; Hastoy, B; Knudsen, JG; Ramracheya, R; Reimann, F; Rorsman, NJG; Rorsman, P; Salehi, A; Spiliotis, II; Tarasov, A; Vergari, E; Wu, Y; Zhang, Q | 1 |
| Araújo, I; Campos, L; Cunha, GJL; Fonseca, C; Gomes, RV; Mendes, G; Morais, R; Rocha, BML | 1 |
| Dicembrini, I; Mannucci, E; Monami, M; Nreu, B | 1 |
| Badimon, JJ; Flores, E; Fuster, V; Garcia-Ropero, A; Hajjar, RJ; Ishikawa, K; Picatoste, B; Requena-Ibanez, JA; San Antonio, R; Santos-Gallego, CG; Sanz, J; Watanabe, S | 1 |
| Bian, F; Chen, L; Jin, S; Wang, Q; Zheng, T | 1 |
| Chen, Q; Liu, M; Wang, T; Xu, J; Yu, H; Zhang, Y | 1 |
| Ahmad, KF; Amen, Y; Ashour, A; Elbermawi, A; Halim, AF; Mansour, ES; Shimizu, K | 1 |
| Moradi-Marjaneh, R; Paseban, M; Sahebkar, A | 1 |
| Hinneburg, I | 1 |
| Kashiwagi, A; Sugimoto, T | 1 |
| Andrianesis, V; Doupis, J | 1 |
| Gerasimova, M; Koepsell, H; Masuda, T; Mayoux, E; Rieg, T; Rose, MA; Satriano, J; Thomson, SC; Vallon, V | 1 |
| Ledford, H | 1 |
| Hansen, CF; Hansen, G; Hansen, HH; Jelsing, J; Klein, T; Mark, M; Mayoux, E; Vrang, N | 1 |
| Navarro, D | 1 |
| Heneghan, CJ; Onakpoya, IJ | 1 |
| Kihara, Y; Nakano, Y; Sairaku, A | 1 |
| Almodóvar Carretón, MJ; Escudero Vilaplana, B; Herrero Hernández, S | 1 |
| Dutta, D; Kalra, S | 1 |
| Mayoux, E; Michel, MC; Vallon, V | 1 |
| Grant, PJ | 1 |
| Bloomgarden, Z | 1 |
| Nakamura, M; Nishio, D; Saito-Sasaki, N; Sawada, Y | 1 |
| Preiss, D; Sattar, N | 1 |
| Harada, M; Kawamura, T; Miyazaki, Y; Nakayama, I; Ogura, M; Okonogi, H; Sato, H; Tokoro, K; Tsuboi, N; Yokoo, T | 1 |
| Carakostas, MC; Magnuson, BA; Moore, NH; Poulos, SP; Renwick, AG | 1 |
| Close, KL; Dove, AE; Gao, HX; Marathe, PH; Odeh, SA | 1 |
| Gilbert, JD; Goldenberg, RM; Perkins, BA; Verma, S; Zinman, B | 1 |
| Cefalu, WT; Grove, O; Hsia, DS | 1 |
| Bhandari, MR; Hong, G; Jong-Anurakkun, N; Kawabata, J | 1 |
| Adolphe, JL; Alcorn, J; Juurlink, BH; Thorpe, LU; Whiting, SJ | 1 |
| Aragão, DM; da Costa, JC; Garcia, RM; Guarize, L; Lanini, J; Scio, E | 1 |
| Ho, CT; Huang, D; Lv, L; Sang, S; Shao, X; Wang, L | 1 |
| Sharma, K; Vallon, V | 1 |
| Kato, E; Kawabata, J | 1 |
| Barrio, JR; Ghezzi, C; Hirayama, BA; Hummel, CS; Kepe, V; Liu, J; Loo, DD; Lu, C; Wright, EM | 1 |
| Cao, A; Liu, Y; Tang, Y | 1 |
| Komala, MG; Mather, A; Panchapakesan, U; Pollock, C | 1 |
| Forbes, J; Gross, S; Komala, MG; Mather, A; Mudaliar, H; Panchapakesan, U; Pegg, K; Pollock, C | 1 |
| Saito, A; Seiyaku, T; Tsujihara, K | 1 |
| ASCIONE, A; LAURIA, D | 1 |
| Demopoulos, VJ; Geromichalos, GD; Koukoulitsa, C; Skaltsa, H; Zika, C | 1 |
| Chang, CL; Chang, SL; Chiang, YM; Shyur, LF; Yang, WC | 1 |
| McCann, P; Meezan, E; Pillion, DJ; Wang, P; Yorks, J | 1 |
| Anai, M; Arakawa, K; Asano, T; Ishirahara, T; Kikuchi, M; Nawano, M; Oku, A; Saito, A; Ueta, K; Umebayashi, I | 1 |
| Baynes, JW; Catalano, EW; Day, JF; McFarland, KF; Thorpe, SR | 1 |
27 review(s) available for glucose, (beta-d)-isomer and Diabetes Mellitus
| Article | Year |
|---|---|
Carbohydrates as recognition molecules in macrophage activities.
Topics: Animals; Binding Sites; Carbohydrate Metabolism; Diabetes Mellitus; Glycoproteins; Humans; Lectins; Macrophages; Major Histocompatibility Complex; Mice; Rats; T-Lymphocytes; Zymosan | 1989 |
Pharmacological effects of polydatin in the treatment of metabolic diseases: A review.
Topics: AMP-Activated Protein Kinases; Atherosclerosis; Diabetes Mellitus; Glucosides; Gout; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Phosphatidylinositol 3-Kinases; Quality of Life; Stilbenes | 2022 |
Salidroside - Can it be a Multifunctional Drug?
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Hypoxia; Metabolic Diseases; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Rhodiola; Wounds and Injuries | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties.
Topics: Animals; Central Nervous System; Diabetes Mellitus; Glucosides; Humans; Neoplasms; Phenols; Rhodiola | 2021 |
The role of metabolites of steviol glycosides and their glucosylated derivatives against diabetes-related metabolic disorders.
Topics: Animals; Diabetes Complications; Diabetes Mellitus; Diterpenes, Kaurane; Glucosides; Glycosides; Humans | 2021 |
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Benzhydryl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bridged Bicyclo Compounds, Heterocyclic; Canagliflozin; Circadian Rhythm; Diabetes Mellitus; Female; Glucosides; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2017 |
[Sodium-Glucose Transporters as a Therapeutic Target for Diabetes from the Viewpoint of Drug Discovery and Pharmacotherapy].
Topics: Body Weight; Carbonates; Diabetes Mellitus; Drug Discovery; Energy Metabolism; Glucosides; Humans; Hypoglycemic Agents; Molecular Targeted Therapy; Phloretin; Phlorhizin; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
Effects of sodium glucose co-transporter 2 inhibitors on the kidney.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Canagliflozin; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Humans; Hypoglycemic Agents; Kidney; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2018 |
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Benzhydryl Compounds; Diabetes Mellitus; Female; Glucosides; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Beneficial Effects of Rhodiola and Salidroside in Diabetes: Potential Role of AMP-Activated Protein Kinase.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Clinical Studies as Topic; Diabetes Mellitus; Drug Evaluation, Preclinical; Energy Metabolism; Enzyme Activation; Glucosides; Humans; Hypoglycemic Agents; Molecular Targeted Therapy; Oxidative Stress; Phenols; Plant Extracts; Rhodiola; Signal Transduction; Structure-Activity Relationship; Treatment Outcome | 2019 |
Natural products with SGLT2 inhibitory activity: Possibilities of application for the treatment of diabetes.
Topics: Benzhydryl Compounds; Biological Products; Canagliflozin; Diabetes Mellitus; Glucosides; Humans; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2019 |
[Dapagliflozin. Lowering blood glucose levels by increasing glucosuria].
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Drug Interactions; Glucosides; Glycosuria; Humans; Hypoglycemic Agents | 2013 |
[The cutting-edge of medicine; novel therapeutic agents for the treatment of diabetes sodium-glucose co-transporter (SGLT) 2 inhibitors].
Topics: Diabetes Mellitus; Glucose; Glucosides; Humans; Hypoglycemic Agents; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2013 |
The role of kidney in glucose homeostasis--SGLT2 inhibitors, a new approach in diabetes treatment.
Topics: Animals; Benzhydryl Compounds; Canagliflozin; Clinical Trials as Topic; Diabetes Mellitus; Gluconeogenesis; Glucose; Glucosides; Homeostasis; Humans; Hypoglycemic Agents; Kidney; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome | 2013 |
Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials.
Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus; Dietary Supplements; Diterpenes, Kaurane; Glucosides; Humans; Hypertension; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sweetening Agents | 2015 |
[Dapagliflozin, a novel oral antidiabetic with an uncertain future].
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Randomized Controlled Trials as Topic | 2014 |
A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucose; Glucosides; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
First case of drug eruption due to ipragliflozin: Case report and review of the literature.
Topics: Aged; Diabetes Mellitus; Drug Eruptions; Glucosides; Humans; Hypoglycemic Agents; Male; Thiophenes | 2017 |
Research digest.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Liraglutide | 2016 |
Biological fate of low-calorie sweeteners.
Topics: Animals; Aspartame; Diabetes Mellitus; Diterpenes, Kaurane; Energy Intake; Glucosides; Humans; Legislation, Drug; Microbiota; Saccharin; Sucrose; Sweetening Agents; Thiazines | 2016 |
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Drug Therapy, Combination; Glucagon; Glucosides; Humans; Hypoglycemic Agents; Incretins; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Hypoglycemic Agents; Insulin; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.
Topics: Animals; Antioxidants; Butylene Glycols; Cardiovascular Diseases; Diabetes Mellitus; Diet; Enzyme Activators; Enzyme Inhibitors; Female; Flax; Glucosides; Humans; Lignin; Neoplasms; Phytoestrogens; Pregnancy | 2010 |
Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.
Topics: Absorption; Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Glucosides; Humans; Kidney; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |
Sodium glucose cotransporter 2 and the diabetic kidney.
Topics: Animals; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Glucosides; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2013 |
[SGLT inhibitor (T-1095)].
Topics: Animals; Carbonates; Diabetes Mellitus; Disease Models, Animal; Drug Design; Energy Metabolism; Glucose; Glucosides; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Kidney; Monosaccharide Transport Proteins | 2002 |
4 trial(s) available for glucose, (beta-d)-isomer and Diabetes Mellitus
| Article | Year |
|---|---|
Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucosides; Glycolipids; Humans; Liraglutide; Metabolic Syndrome; Quality of Life; Stroke Volume; Uric Acid; Ventricular Function, Left | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Effect of dapagliflozin in patients with heart failure.
Topics: Aged; Benzhydryl Compounds; Diabetes Mellitus; Female; Glucosides; Heart Failure; Hospitalization; Humans; Kidney Diseases; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Empagliflozin Targeting the Real-World Heart Failure Population.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus; Drug Delivery Systems; Female; Follow-Up Studies; Glucosides; Heart Failure; Humans; Male; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
86 other study(ies) available for glucose, (beta-d)-isomer and Diabetes Mellitus
| Article | Year |
|---|---|
Hyperglycemia and Some Aspects of Leukocyte Activation In Vitro.
Topics: Diabetes Mellitus; Extracellular Traps; Humans; Hyperglycemia; Leukocytes; Luminescent Measurements; Neutrophils; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Zymosan | 2021 |
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.
Topics: Adult; Diabetes Mellitus; Female; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Middle Aged; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Nerve Growth Factors; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Structure-Activity Relationship; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 2007 |
Oxygen metabolism of phagocytosing human polymorphonuclear leucocytes in diabetes mellitus.
Topics: Aged; Diabetes Mellitus; Female; Glucose; Humans; Hyperglycemia; Male; Neutrophils; Oxygen Consumption; Phagocytes; Phagocytosis; Superoxides; Zymosan | 1984 |
Chemiluminescence and superoxide anion production by leukocytes from diabetic patients.
Topics: Adult; Aged; Anions; Diabetes Mellitus; Glucagon; Humans; Kinetics; Luminescent Measurements; Middle Aged; Neutrophils; Opsonin Proteins; Oxygen; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1983 |
Diminished production of thromboxane B2 and prostaglandin E by stimulated polymorphonuclear leukocytes from insulin-treated diabetic subjects.
Topics: Arachidonic Acids; Blood Glucose; Blood Platelets; Cell Separation; Diabetes Mellitus; Female; Humans; Insulin; Male; Middle Aged; Neutrophils; Prostaglandins E; Staphylococcus aureus; Thromboxane B2; Thromboxanes; Zymosan | 1983 |
Study of phagocytic function with a quantitative nitroblue-Tetrazolium (NBT) reduction test in diabetes mellitus.
Topics: Adult; Aged; Diabetes Mellitus; Female; Granulocytes; Humans; Male; Middle Aged; Nitroblue Tetrazolium; Oxidation-Reduction; Phagocytosis; Tetrazolium Salts; Zymosan | 1980 |
Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia.
Topics: Adult; Blood Glucose; Calcimycin; Cells, Cultured; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hyperglycemia; Leukotriene B4; Lysosomes; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Zymosan | 2001 |
Phagocytosis, bactericidal capacity, and superoxide anion (O2-) production by polymorphonuclear neutrophils from patients with diabetes mellitus.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Bactericidal Activity; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Middle Aged; Neutrophils; Phagocytosis; Staphylococcus; Superoxides; Zymosan | 1985 |
Candida albicans and the fungicidal activity of the blood.
Topics: Adsorption; Antigens, Fungal; Blood Specimen Collection; Candida albicans; Cell Survival; Cell Wall; Complement System Proteins; Cytoplasm; Diabetes Mellitus; Humans; Leukocytes; Phagocytosis; Plasma; Spores, Fungal; Time Factors; Zymosan | 1972 |
Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Mice; Mice, Inbred Strains; Proteinuria; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetic Nephropathies; Epithelial Cells; Glucose; Glucosides; Humans; Hypoglycemic Agents; In Situ Hybridization, Fluorescence; Metformin; MicroRNAs; RNA, Circular; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin | 2022 |
SGLT2 inhibitors therapy protects glucotoxicity-induced β-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Gain of Function Mutation; Glucosides; Humans; Infant, Newborn; Infant, Newborn, Diseases; Insulin-Secreting Cells; KATP Channels; Male; Mice; Mice, Transgenic; Oxidative Stress; Protective Agents; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2022 |
Paeoniflorin inhibits epithelial mesenchymal transformation and oxidative damage of lens epithelial cells in diabetic cataract via sirtuin 1 upregulation.
Topics: Cataract; Diabetes Mellitus; Epithelial Cells; Epithelial-Mesenchymal Transition; Glucosides; Humans; Lens, Crystalline; Monoterpenes; Oxidative Stress; Sirtuin 1; Up-Regulation | 2022 |
Paeoniflorin Upregulates Mitochondrial Thioredoxin of Schwann Cells to Improve Diabetic Peripheral Neuropathy Indicated by 4D Label-Free Quantitative Proteomics.
Topics: Animals; Diabetes Mellitus; Diabetic Neuropathies; Glucosides; Monoterpenes; Proteomics; Rats; Schwann Cells; Thioredoxins | 2022 |
Dapagliflozin Attenuates Contrast-induced Acute Kidney Injury by Regulating the HIF-1α/HE4/NF-κB Pathway.
Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Contrast Media; Diabetes Mellitus; Glucosides; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Rats; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Glucagon-Like Peptides; Glucosides; Humans; Insulin; Insulin Resistance | 2022 |
Reply to the Letter to the editor "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD".
Topics: Diabetes Mellitus; Glucosides; Humans; Non-alcoholic Fatty Liver Disease; Thiophenes | 2022 |
Reply to: "Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD".
Topics: Diabetes Mellitus; Glucosides; Humans; Non-alcoholic Fatty Liver Disease; Thiophenes | 2022 |
The efficacy of a paeoniflorin-sodium alginate-gelatin skin scaffold for the treatment of diabetic wound: An in vivo study in a rat model.
Topics: Alginates; Animals; Collagen; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Gelatin; Glucosides; Microvessels; Monoterpenes; Printing, Three-Dimensional; Rats; Skin; Tissue Scaffolds; Wound Healing; Wounds and Injuries | 2022 |
Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA.
Topics: Aged; Benzhydryl Compounds; Cost-Benefit Analysis; Diabetes Mellitus; Diabetic Nephropathies; Drug-Related Side Effects and Adverse Reactions; Glucosides; Humans; Medicare; Quality-Adjusted Life Years; Standard of Care; United States | 2022 |
Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucose; Glucosides; Humans; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetic Ketoacidosis; Glucose; Glucosides; Glycemic Control; Humans; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
The incidence of diabetic ketoacidosis associated with empagliflozin use in Aotearoa New Zealand: a preliminary review.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetic Ketoacidosis; Glucosides; Humans; Incidence; New Zealand | 2022 |
Effects of 3 months of treatment with empagliflozin on left ventricle global longitudinal strain and myocardial mechano-energetic effiency.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Heart Ventricles; Humans; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function, Left | 2022 |
Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Diabetic Nephropathies; Ferroptosis; Glucosides; Mice; Mice, Inbred C57BL | 2022 |
Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
Topics: Animals; Apoptosis; Autophagy; Caspase 3; Class I Phosphatidylinositol 3-Kinases; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Mice; Molecular Docking Simulation; Monoterpenes; Phosphatidylinositol 3-Kinases; Podocytes; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Fibrosis; Glucosides; Male; Rabbits; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.
Topics: Animals; Benzhydryl Compounds; Chromatography, Liquid; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Kidney; Mice; Proteomics; Sodium-Glucose Transporter 2 Inhibitors; Tandem Mass Spectrometry | 2022 |
In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Heart Failure; Hospitalization; Humans; Stroke Volume; Ventricular Function, Left | 2022 |
Blueberry Anthocyanins from Commercial Products: Structure Identification and Potential for Diabetic Retinopathy Amelioration.
Topics: Anthocyanins; Blueberry Plants; Diabetes Mellitus; Diabetic Retinopathy; Glucosides; Molecular Docking Simulation; NF-E2-Related Factor 2; Tandem Mass Spectrometry | 2022 |
Antioxidant Activity of Cyanidin-3-O-Glucoside and Verbascoside in an
Topics: Antioxidants; Diabetes Mellitus; Diabetic Retinopathy; Endothelial Cells; Glucose; Glucosides; Humans; Reactive Oxygen Species | 2022 |
Use of Empagliflozin in Recipients of Kidney Transplant: A Report of 8 Cases.
Topics: Adult; Benzhydryl Compounds; Calcineurin Inhibitors; Diabetes Mellitus; Female; Glucosides; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Tacrolimus; Treatment Outcome | 2019 |
Anti-insulin resistance effects of salidroside through mitochondrial quality control.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus; Glucose; Glucosides; Humans; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mitochondria; Phenols; Reactive Oxygen Species; Sirtuin 1 | 2020 |
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Topics: Angiotensin II; Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Glucosides; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Ventricular Function, Left | 2020 |
Salidroside ameliorates diabetic nephropathy in rats by activating renal AMPK/SIRT1 signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Kidney; Phenols; Rats; Signal Transduction; Sirtuin 1 | 2020 |
Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome.
Topics: Adult; Biomarkers; Blood Glucose; Diabetes Mellitus; Female; Glucosides; Glycated Hemoglobin; Humans; Insulin Resistance; Prognosis; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2020 |
A Novel Cardioprotective Therapy That Also Improves Glycemia.
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Glucosides; Heart Failure; Humans | 2020 |
Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
Topics: Adolescent; Benzhydryl Compounds; Blood Glucose; Child; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Glucosides; Humans; Liraglutide; Prader-Willi Syndrome; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2020 |
Discontinuation rate and reason for discontinuation after sodium-glucose cotransporter 2 inhibitor prescription in real clinical practice.
Topics: Adult; Age Factors; Aged; Benzhydryl Compounds; Blood Glucose; Cohort Studies; Diabetes Mellitus; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors | 2020 |
Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?
Topics: Albuminuria; Benzhydryl Compounds; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Glucosides; Humans; Kidney; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Regression of left ventricular hypertrophy with SGLT2 inhibitors.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Humans; Hypertrophy, Left Ventricular; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Dapagliflozin reduces left ventricular mass.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Humans; Hypertrophy, Left Ventricular | 2020 |
5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Drug Design; Glucose Tolerance Test; Glucosides; Half-Life; Halogenation; Humans; Hypoglycemic Agents; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Microsomes; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Structure-Activity Relationship | 2020 |
Empagliflozin improves outcomes in HFrEF regardless of diabetic status.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Heart Failure; Humans; Stroke Volume | 2020 |
SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus; Glucosides; Humans; Kidney; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 | 2021 |
SGLT2 inhibitors: expanding their Empire beyond diabetes.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Double-Blind Method; Glomerular Filtration Rate; Glucosides; Heart Failure; Humans; Plasma Volume; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Chondroprotective effects of purple corn anthocyanins on advanced glycation end products induction through suppression of NF-κB and MAPK signaling.
Topics: Anthocyanins; Cartilage; Cell Line; Chondrocytes; Diabetes Complications; Diabetes Mellitus; Glucosides; Glycation End Products, Advanced; Glycosaminoglycans; Humans; Hydroxybenzoates; Inflammation; MAP Kinase Signaling System; NF-kappa B; Osteoarthritis; Zea mays | 2021 |
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Humans; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac | 2021 |
Verbascoside-enriched fraction from Buddleja cordata Kunth ameliorates the effects of diabetic embryopathy in an animal model.
Topics: Animals; Buddleja; Diabetes Mellitus; Disease Models, Animal; Fetal Diseases; Glucosides; Phenols; Pregnancy; Rats | 2021 |
A natural product of acteoside ameliorate kidney injury in diabetes db/db mice and HK-2 cells via regulating NADPH/oxidase-TGF-β/Smad signaling pathway.
Topics: Animals; Biological Products; Cell Line; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Humans; Kidney; Male; Mice; NADP; NADPH Oxidases; Phenols; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2021 |
Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report.
Topics: Adult; Diabetes Mellitus; Fatty Liver; Glucosides; Glycated Hemoglobin; Humans; Insulin Resistance; Lipodystrophy; Male; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2017 |
Empagliflozin in the management of diabetes mellitus after cardiac transplantationResearch Correspondenceretain-->.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Disease Management; Female; Glucosides; Heart Transplantation; Humans; Male; Middle Aged; Postoperative Complications; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
Dapagliflozin associated ketoacidosis: A must know fact for nephrologists.
Topics: Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus; Female; Glucosides; Humans; Ketosis; Middle Aged; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
A new flavone glucoside together with known ellagitannins and flavones with anti-diabetic and anti-obesity activities from the flowers of pomegranate (Punica granatum).
Topics: alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus; Flavones; Flowers; Glucosides; Hydrolyzable Tannins; Lipase; Lythraceae; Obesity; Plant Extracts; Structure-Activity Relationship | 2019 |
Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus; Disease Models, Animal; Glucosides; Homeostasis; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; Male; Pancreas; Proteinuria; Rats, Inbred SHR; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Ferulic acid may target MyD88-mediated pro-inflammatory signaling - Implications for the health protection afforded by whole grains, anthocyanins, and coffee.
Topics: Adiponectin; Administration, Oral; Animals; Anthocyanins; Anti-Inflammatory Agents; Antioxidants; Coffee; Coumaric Acids; Diabetes Mellitus; Gastrointestinal Microbiome; Glucosides; Glutathione; Humans; Inflammation; Myeloid Differentiation Factor 88; Osteoclasts; Oxidative Stress; Rats; Signal Transduction; Whole Grains | 2018 |
Single dose of empagliflozin increases in vivo cardiac energy status in diabetic db/db mice.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Energy Metabolism; Glucosides; Ketones; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphocreatine; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function | 2018 |
Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus; Female; Glucosides; Humans; Life Expectancy; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Survival Analysis; Time Factors; Treatment Outcome | 2018 |
SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Canagliflozin; Diabetes Mellitus; Diet, High-Fat; Disease Models, Animal; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Glucosides; Glycosuria; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Female; Glucagon; Glucagon-Secreting Cells; Glucosides; Humans; Hypoglycemia; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Insulin; Receptors, Somatostatin; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Somatostatin | 2019 |
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Diabetes Mellitus; Disease Models, Animal; Echocardiography, Three-Dimensional; Glucosides; Heart Failure; Heart Function Tests; Random Allocation; Reference Values; Sodium-Glucose Transporter 2 Inhibitors; Statistics, Nonparametric; Stroke Volume; Swine; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Leaves of Lippia triphylla improve hepatic lipid metabolism via activating AMPK to regulate lipid synthesis and degradation.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus; Fatty Acid Synthase, Type I; Glucosides; Lipase; Lipid Metabolism; Lipolysis; Lippia; Liver; Male; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Phenols; Phosphorylation; Plant Extracts; Plant Leaves; Triglycerides | 2019 |
A new glucoside with a potent α-glucosidase inhibitory activity from
Topics: 1-Butanol; Acetates; alpha-Glucosidases; Chemical Fractionation; Diabetes Mellitus; Glucosides; Glycoside Hydrolase Inhibitors; Humans; Lycium; Methanol; Plant Extracts | 2021 |
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Topics: Adipocytes; Albuminuria; Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; Blotting, Western; Diabetes Mellitus; Diabetic Nephropathies; Drinking; Eating; Glomerular Filtration Rate; Glucosides; Heart Rate; Hyperglycemia; Inflammation; Kidney; Kidney Glomerulus; Mice; Mice, Inbred Strains; Real-Time Polymerase Chain Reaction; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2014 |
Diabetes drugs ride a bumpy road.
Topics: Benzhydryl Compounds; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Glucosides; Heart Diseases; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2013 |
The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves β-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus; Glucosides; Homeostasis; Insulin-Secreting Cells; Male; Random Allocation; Rats; Rats, Zucker; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2014 |
A report from the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD) (September 15-19, 2014 - Vienna, Austria).
Topics: Animals; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus; Diabetic Nephropathies; Glucosides; Humans; Linagliptin | 2014 |
Increased urine output by ipragliflozin in a non-diabetic patient with a diuretic-resistant heart failure.
Topics: Diabetes Mellitus; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Female; Glucosides; Heart Failure; Humans; Middle Aged; Stroke Volume; Thiophenes | 2015 |
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2014 |
Empagliflozin in diabetes: A therapeutic light at the end of the cardiovascular tunnel?
Topics: Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents | 2015 |
Glycemic control and the heart: it matters how you get there.
Topics: Benzhydryl Compounds; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Liraglutide; Outcome Assessment, Health Care; Pioglitazone; Thiazolidinediones | 2016 |
Fluctuation in Serum Sodium Levels Related to Ipragliflozin Administration in a Patient with Diabetic Nephropathy and Sequela of Traumatic Brain Injury.
Topics: Brain Injuries, Traumatic; Diabetes Mellitus; Diabetic Nephropathies; Fludrocortisone; Glucosides; Humans; Hyponatremia; Insulin; Male; Middle Aged; Sodium; Thiophenes | 2016 |
Diabetes News.
Topics: Benzhydryl Compounds; Congresses as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Glucagon-Like Peptides; Glucosides; Humans; Hypoglycemic Agents; Peptides; Treatment Outcome; Venoms | 2017 |
Alpha-glucosidase inhibitor from Chinese aloes.
Topics: Aloe; Animals; Blood Glucose; Chromones; Diabetes Mellitus; Drugs, Chinese Herbal; Enzyme Inhibitors; Glucosides; Glycoside Hydrolase Inhibitors; Inhibitory Concentration 50; Molecular Structure; Phytotherapy; Plant Leaves; Rats | 2008 |
Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Cecropia Plant; Diabetes Mellitus; Diabetes Mellitus, Type 2; Flavonoids; Free Radical Scavengers; Glucose Tolerance Test; Glucosides; Glyburide; Hypoglycemic Agents; Male; Medicine, Traditional; Metformin; Phenols; Plant Extracts; Rats; Rats, Wistar | 2010 |
Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal.
Topics: Chromatography, Liquid; Diabetes Complications; Diabetes Mellitus; Glucosides; Glycation End Products, Advanced; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Conformation; Polygonum; Pyruvaldehyde; Resveratrol; Stilbenes | 2010 |
Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds.
Topics: 3T3-L1 Cells; Animals; Diabetes Mellitus; Glucose; Glucosides; Isoflavones; Mice | 2010 |
Structural selectivity of human SGLT inhibitors.
Topics: Benzhydryl Compounds; Biological Transport; Diabetes Mellitus; Glucose; Glucosides; HEK293 Cells; Humans; Kidney; Molecular Structure; Patch-Clamp Techniques; Phlorhizin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Substrate Specificity | 2012 |
Novel fluorescent biosensor for α-glucosidase inhibitor screening based on cationic conjugated polymers.
Topics: alpha-Glucosidases; Biosensing Techniques; Cations; Diabetes Mellitus; Fluorenes; Fluorescent Dyes; Glucosides; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Nitrophenols; Nitrophenylgalactosides; Polymers; Quaternary Ammonium Compounds; Spectrophotometry | 2012 |
Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Topics: Benzhydryl Compounds; Collagen Type IV; Diabetes Mellitus; Diabetic Nephropathies; Epithelial Cells; Gene Expression; Glucose; Glucosides; Humans; Hypoglycemic Agents; Interleukin-6; Kidney Tubules, Proximal; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Smad3 Protein; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Toll-Like Receptor 4; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2013 |
[Study of the blood sugar curve after glucose loading in diabetics before and after the administration of 50 mg. of desoxycorticosterone glucoside].
Topics: Blood Glucose; Desoxycorticosterone; Diabetes Mellitus; Glucose; Glucosides; Humans; Pharmaceutical Preparations | 1958 |
Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
Topics: Aldehyde Reductase; Animals; Binding Sites; Cinnamates; Computer Simulation; Crystallography, X-Ray; Databases, Factual; Depsides; Diabetes Mellitus; Enzyme Inhibitors; Glucosides; Humans; Hydrogen Bonding; Models, Molecular; NADP; Origanum; Rosmarinic Acid; Static Electricity; Structure-Activity Relationship | 2006 |
Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator.
Topics: Animals; Bidens; Cell Differentiation; Diabetes Mellitus; Gene Expression Regulation; Glucosides; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred BALB C; Phytotherapy; Plant Extracts; Plants, Medicinal; Polyynes; Quality Control; Spleen; T-Lymphocytes, Helper-Inducer | 2007 |
Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog.
Topics: Absorption; Administration, Topical; Animals; Blood Glucose; Detergents; Diabetes Mellitus; Dogs; Drug Carriers; Eye; Gastrointestinal Agents; Glucagon; Glucosides; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Nasal Mucosa; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley | 1995 |
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Carbonates; Diabetes Mellitus; Glucokinase; Glucose Transporter Type 4; Glucose-6-Phosphatase; Glucosides; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Liver; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Rats; Rats, Zucker | 2000 |
Nonenzymatic glucosylation of serum proteins in diabetes mellitus.
Topics: Blood Proteins; Diabetes Mellitus; Erythrocytes; Glucosides; Glycosides; Humans; Regression Analysis | 1979 |